Balanced news tone
News Sentiment
BNTXN sentiment intelligence
BioNTech SE news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
15 relevant articles
Price is moving more forcefully than the current news tone suggests.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-4.5% over one week, -1.5% over four weeks, trend inactive, and near fair-value range.
Is BioNTech (BNTX) a Good Value Stock to Buy Now?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
75/100 classification
One-week reaction
-4.5%
Price reacting lower
Trend fit
Trend inactive
-1.5% over four weeks
Fair value
-16.2%
Near fair-value range
Market Dynamics buy signal
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
5
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
HarianBasis.co
Direct company coverage
Is BioNTech (BNTX) a Good Value Stock to Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jun 2026 02:26
- Source
- HarianBasis.co
Investing.com
Direct company coverage
Bernstein reiterates BioNTech stock rating on pumitamig risks
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 05 Jun 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Bernstein initiates BioNTech stock coverage citing pipeline concerns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
BioNTech earnings ahead: Can oncology offset plunging vaccine sales?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
BMO cuts BioNTech stock price target on CEO departure plans
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 11 Mar 2026 07:00
- Source
- Investing.com
Barchart.com
Direct company coverage
BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Barchart.com
Investing.com
Direct company coverage
Morgan Stanley reiterates Overweight on BioNTech stock at $134
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Micron and BioNTech among market cap stock movers on Tuesday
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
Oppenheimer maintains BioNTech stock rating amid leadership exit
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
BioNTech tumbles over 19% on fourth quarter earnings miss
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
BioNTech stock price target lowered to $167 by Clear Street
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 10 Mar 2026 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
CureVac shares to be delisted from Nasdaq following BioNTech acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jan 2026 08:00
- Source
- Investing.com
Reuters
Direct company coverage
BioNTech's Q2 revenues double on higher COVID vaccine sales
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Aug 2025 07:00
- Source
- Reuters
Investing.com
Direct company coverage
Earnings call transcript: BioNTech beats Q4 2024 expectations, stock dips
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 10 Mar 2025 07:00
- Source
- Investing.com
Investing.com
Direct company coverage
BioNTech stock sees upgrade as Goldman Sachs eyes BNT327 opportunity
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 08 Nov 2024 08:00
- Source
- Investing.com